Abstract：Objective: To investigate the features of Montreal classification in 134 cases with Crohn's disease (CD) and related risk factors of poor prognosis. Methods: The clinical data of CD patients who were admitted to the hospital from July 2015 to February 2018 were retrospectively analyzed. Montreal classifying was performed on them. The clinical features of different classification patients were compared. The risk factors of prognosis were analyzed. Results: Among the 134 patients, there were 82 (61.19%) male, and 52 (38.81%) female, with male to female ratio of 1.58:1. The confirmed age was mainly on A2, accounting for 76.12%. The lesion location was mainly on L3, accounting for 55.22%. The disease behavior was mainly on B1 type, accounting for 67.91%. There were significant differences in disease behavior distribution among patients with different lesions location subtypes (P<0.05). The proportion of B1 type in L4 patients was significantly lower than that in other types, while proportion of B2 type was higher than that in other types. The proportion of B1 type in L3 patients was higher than that in other types, while proportion of B2 type was lower than that in other types. All patients were followed up. There were 56 cases with poor prognosis and 78 cases with good prognosis. Univariate analysis showed that perianal lesions and disease behavior were associated with prognosis of CD patients (P<0.05). Logistic multivariate analysis showed that perianal lesions, B2 and B3 types as disease behaviors were independent risk factors for poor prognosis of CD patients (P<0.05). Conclusion: There are certain differences in clinical features among patients with different Montreal classifications. The perianal lesions and disease behavior are closely related to poor prognosis of patients. Montreal classification can be applied as a reference index for disease assessment, diagnosis and prognosis judgement.
赵甲秀. 134例克罗恩病蒙特利尔分型特征分析及预后不良相关危险因素分析[J]. 河北医学, 2019, 25(12): 2087-2091.
ZHAO Jiaxiu. Features of Montreal Classification in 134 Cases with Crohn's Disease and Related Risk Factors of Poor Prognosis. HeBei Med, 2019, 25(12): 2087-2091.
[1] 巫协宁.克罗恩病发病机制中的重要因素:种族还是遗传[J].国际消化病杂志,2017,37(2):71~72. [2] Bouhnik Y, Carbonnel F, Laharie D, et al. 287 Efficacy of adalimumab in patients with crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort study (CREOLE)[J]. Gastroenterology, 2018, 67(1):53~60. [3] Spekhorst L M,Visschedijk M C,Alberts R,et al.Performance of the Montreal classification for inflammatory bowel diseases[J].World Gastroenterol,2014,20(41):15374. [4] Freeman H J.Application of the montreal classification for crohn's disease to a single clinician database of 1015 patients.[J]Can Gastroenterol.2016,9(11):18~19. [5] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2012年·广州)[J].中华内科杂志,2012,51(10):818~831. [6] Kaminski J P, Zaghiyan K, Fleshner P. Increasing experience of ligation of the intersphincteric fistula tract for patients with crohn's disease: what have we learned[J]. Colorectal Disease, 2017, 19(8):15~17. [7] Braithwaite G C, Lee M J, Hind D, et al. Prognostic factors affecting outcomes in fistulating perianal crohn’s disease: a systematic review[J].Tech Coloproctol, 2017, 21(7):501~519. [8] 孙国强, 姜华.克罗恩病肠切除术后复发的预测及预防[J].现代仪器与医疗,2018,24(1):47~49. [9] Wright E K, Kamm M A, Wagner J, et al. Microbial factors associated with postoperative crohn’s disease recurrence[J]. Journal of Crohns & Colitis, 2017, 11(2):191. [10] Fumery M, Dulai P S, Meirick P, et al. Systematic review with meta-analysis: recurrence of crohn's disease after total colectomy with permanent ileostomy[J]. Aliment Pharmacol Ther, 2017, 45(3):381.
2019, Vol. 25 
冀公网安备13080202000677号